{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-083793","form_type":"8-K","ticker":"AXSM","cik":"0001579428","company_name":"Axsome Therapeutics, Inc.","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.861931+00:00","generated_at":"2026-05-19T17:10:05.210900+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Axsome stockholders approve all four proposals at 2025 annual meeting","bullets":["Elected Roger A. Jeffs as Class I director with 27.3M votes for, 8.1M withheld.","Approved 2025 Long-Term Incentive Plan with 26.4M for, 8.9M against.","Ratified Deloitte & Touche as auditor for FY2025 with 40.8M for, 225.7K against.","Advisory say-on-pay passed with 34.8M for, 528.2K against.","Approximately 84% of shares (41.4M of 49.2M) represented at meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-083793","json":"https://secwatch.observer/filing/0000950170-25-083793.json","markdown":"https://secwatch.observer/filing/0000950170-25-083793.md","text":"https://secwatch.observer/filing/0000950170-25-083793.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025083793/0000950170-25-083793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1579428/000095017025083793/axsm-20250606.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T17:10:05.210900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}